Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | CTSC | P53634 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | CTRC | Q99895 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19361050 | 0.79 | CYP1A2 (0.41) | CYP2D6CYP3A4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2838141 | 0.77 | CYP1A2 (0.65) | CYP2D6CYP1A2CYP2A6ALOX5CTRC | |
| SCHEMBL28300839 | 0.77 | MET (0.51) | ALDH1A1TSHR | |
| SCHEMBL45228 | 0.76 | LMNA (0.50) | SLC6A3ALDH1A1HPGDPTGS1PTGS2 | |
| SCHEMBL4084648 | 0.74 | PTGS1 (0.57) | ALDH1A1HPGDPTGS1PTGS2LMNA | |
| SCHEMBL6222184 | 0.74 | CA1 (0.57) | CYP2D6SLC6A2SLC6A3CYP1A2ALOX5 | |
| SCHEMBL29152299 | 0.74 | PTGS1 (0.51) | ALDH1A1HPGDPTGS1PTGS2LMNA | |
| SCHEMBL7079573 | 0.74 | L3MBTL1 (0.66) | SLC6A2SLC6A4SLC6A3ALDH1A1HPGD | |
| SCHEMBL28047877 | 0.74 | KCNH2 (0.46) | CYP3A4KCNH2GAAPTGS1PTGS2 | |
| SCHEMBL9825918 | 0.74 | LMNA (0.49) | SLC6A3ALDH1A1HPGDPTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10800895-B2 | Polymer slides having hydrophobic small molecules | STRATEC CONSUMABLES GmbH (AT) | 2020-10-13 | — | — | US | disclosed |
| US-10611890-B2 | Method of producing a polymer part and polymer part | STRATEC CONSUMABLES GmbH (AT) | 2020-04-07 | — | — | US | disclosed |
| EP-2792471-B1 | Polymer parts | STRATEC CONSUMABLES GmbH (AT) | 2018-01-31 | — | — | EP | disclosed |
| US-20170029587-A1 | METHOD OF PRODUCING A POLYMER PART AND POLYMER PART | STRATEC CONSUMABLES GmbH (AT) | 2017-02-02 | — | — | US | disclosed |
| EP-2792471-A1 | Polymer parts | Sony DADC Austria AG (AT) | 2014-10-22 | — | — | EP | disclosed |
| US-20140309375-A1 | METHOD OF PRODUCING A POLYMER PART AND POLYMER PART | SONY DADC AUSTRIA AG (AT) | 2014-10-16 | — | — | US | disclosed |
| US-20070276138-A1 | Modulators of peroxisome proliferator activated receptors | BROOKS DAWN A | 2007-11-29 | — | — | US | disclosed |
| EP-0326297-B1 | THIOFORMAMIDE DERIVATIVES | MAY & BAKER LIMITED (GB) | 1992-03-18 | — | — | EP | disclosed |
| US-4959385-A | MUSCLE RELAXANTS | MAY & BAKER LIMITED (GB) | 1990-09-25 | — | — | US | disclosed |
| EP-0326297-A1 | Thioformamide derivatives | MAY & BAKER LIMITED (GB) | 1989-08-02 | — | — | EP | disclosed |
| US-4276305-A | INSECTICIDES, MITICIDES | HOFFMANN-LA ROCHE INC. (US) | 1981-06-30 | — | — | US | disclosed |
| EP-0014455-A2 | Cyclopropane(thiol)carboxylic-acid esters, processes for their preparation, pesticides containing such compounds and the use of such compounds as pesticides | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1980-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070276138-A1 | Modulators of peroxisome proliferator activated receptors | PPARG, NCOA4, PPARA | CYP2D6 468/4885CYP3A4 172/4885SLC6A2 3223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.